Medizinische Universität Graz - Research portal

Go directly to the nagivation.
Go directly to the content.

Navigation/Search

Researchers.
- Curriculum.
- Publications.
- Presentations.
- Advised theses.
Institutions.
Projects.
Publications.
Partners.
Sponsors.
Equipment.
Knowhow.
Fields of Research.

Jaeger Gerald |

Publications

** = Publications listed in SCI/SSCI/Pubmed

2010

Abstract (Journal)

** Krieger, O; Machhemdl-Spandl, S; Hauser, H; Binder, M; Greinix, H; Eder, S; Kahls, P; Rabitsch, W; Nachbaur, D; Ludwig, H; Linkesch, W; Jaeger, G; Sill, H; Lindner, B Stem cell transplantation for MDS patients 1987-2008: data from the Austrian transplant registry (ASCTR)
BONE MARROW TRANSPLANT. 2010; 45: S180-S181. -36th Annual Meeting of the European Group for Blood and Marrow Transplantation; MAR 21-24, 2010; Vienna, AUSTRIA. [Poster]
Web of Science

** Reitter, S; Bauer, F; Jager, G; Linkesch, W; Langner, S Targeted inhibition of angiogenesis suggests a promising therapeutic option in Histiocytic Sarcoma
ONKOLOGIE. 2010; 33: 178-179. [Poster]
Web of Science

2008

Short report/Letter

** Jaeger, G; Bauer, F; Brezinschek, R; Beham-Schmid, C; Mannhalter, C; Neumeister, P Hepatosplenic gammadelta T-cell lymphoma successfully treated with a combination of alemtuzumab and cladribine.
ANN ONCOL. 2008; 19(5): 1025-1026. Doi: 10.1093/annonc/mdn119 (- Case Report) [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

2007

Short report/Letter

** Jäger, G; Quehenberger, F; Linkesch, W; Neumeister, P CHOP chemotherapy followed by Rituximab consolidation as first line treatment in patients with follicular lymphoma. Long-term follow-up of a phase 2 trial.
EUR J HAEMATOL. 2007; 78(5): 453-455. Doi: 10.1111/j.1600-0609.2007.00848.x
Web of Science PubMed FullText FullText_MUG Google Scholar

2006

Short report/Letter

** Jager, G; Neumeister, P; Quehenberger, F; Wohrer, S; Linkesch, W; Raderer, M Prolonged clinical remission in patients with extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type treated with cladribine: 6 year follow-up of a phase II trial.
ANN ONCOL. 2006; 17(11): 1722-1723. Doi: 10.1093/annonc/mdl126 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

2005

Full paper/article (Journal)

** Jaeger, G; Linkesch, W; Temmel, W; Neumeister, P AntiCD20 monoclonal antibody-based radioimmunotherapy of relapsed chemoresistant aggressive post-transplantation B-lymphoproliferative disorder in heart-transplant recipient.
LANCET ONCOL. 2005; 6(8): 629-631. Doi: 10.1016/S1470-2045(05)70286-2 (- Case Report)
Web of Science PubMed FullText FullText_MUG Google Scholar

2004

Full paper/article (Journal)

** Jäger, G; Höfler, G; Linkesch, W; Neumeister, P Occurrence of a myelodysplastic syndrome (MDS) during first-line 2-chloro-deoxyadenosine (2-CDA) treatment of a low-grade gastrointestinal MALT lymphoma. Case report and review of the literature.
Haematologica. 2004; 89(4): ECR01-ECR01. (- Case Report) [OPEN ACCESS]
PubMed FullText Google Scholar

2003

Full paper/article (Journal)

** Raderer, M; Jäger, G; Brugger, S; Püspök, A; Fiebiger, W; Drach, J; Wotherspoon, A; Chott, A Rituximab for treatment of advanced extranodal marginal zone B cell lymphoma of the mucosa-associated lymphoid tissue lymphoma.
Oncology. 2003; 65(4):306-310 Doi: 10.1159/000074641
Web of Science PubMed FullText FullText_MUG

2002

Full paper/article (Journal)

** Jäeger, G; Neumeister, P; Brezinschek, R; Höfler, G; Quehenberger, F; Linkesch, W; Sill, H Rituximab (anti-CD20 monoclonal antibody) as consolidation of first-line CHOP chemotherapy in patients with follicular lymphoma: a phase II study.
EUR J HAEMATOL 2002 69: 21-26. Doi: 10.1034%2Fj.1600-0609.2002.01692.x
Web of Science PubMed FullText FullText_MUG

** Jäger, G; Neumeister, P; Brezinschek, R; Hinterleitner, T; Fiebiger, W; Penz, M; Neumann, HJ; Mlineritsch, B; DeSantis, M; Quehenberger, F; Chott, A; Beham-Schmid, C; Höfler, G; Linkesch, W; Raderer, M Treatment of extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type with cladribine: a phase II study.
J Clin Oncol. 2002; 20(18):3872-3877 Doi: 10.1200/JCO.2002.05.117 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

2001

Full paper/article (Journal)

** Neumeister, P; Jaeger, G; Eibl, M; Sormann, S; Zinke, W; Linkesch, W Amifostine in combination with erythropoietin and G-CSF promotes multilineage hematopoiesis in patients with myelodysplastic syndrome.
Leuk Lymphoma. 2001; 40(3-4):345-349 Doi: 10.3109/10428190109057933
Web of Science PubMed FullText FullText_MUG Google Scholar

2000

Abstract (Journal)

** Jager, G; Brezinschek, R; Neumeister, P; Linkesch, W Consolidation with Rituximab(Mab-Thera (TM)) after CHOP-induction as first-line treatment of follicular lymphoma. A phase II study.
BLOOD 2000 96: 240B-240B.
Web of Science

1998

Full paper/article (Journal)

** Fridrik, MA; Jäger, G; Kienzer, HR; Hausmaninger, H; Oppitz, P; Krieger, O; Zabernigg, A; Lang, A; Neubauer, M; Weidinger, G; Schiller, L; Seewann, HL; Chott, A; Linkesch, W Efficacy and toxicity of 2-Chlorodeoxyadenosine (Cladribine)--2 h infusion for 5 days--as first-line treatment for advanced low grade non-Hodgkin's lymphoma.
Eur J Cancer. 1998; 34(10):1560-1564 Doi: 10.1016%2FS0959-8049%2898%2900140-3
Web of Science PubMed FullText FullText_MUG Google Scholar

Abstract (Journal)

** Gilli, R; Helmberg, W; Jager, G; Schmidt, H; Sipurzynski, S; Wagner, T; Linkesch, W; Lanzer, G Production of peripheral blood stem cell autografts for adults suffering from haematological disorders.
BONE MARROW TRANSPLANT 1998 21: S195-S195.
Web of Science

** Jager, G; Neumeister, P; Hinterleitner, T; Hofler, G; Brezinschek, R; Linkesch, W Cladribine (2-CDA) as a therapy for low-grade MALT-lymphoma: An organ-preserving therapeutic concept.
BLOOD 1998 92: 236B-237B.
Web of Science

** Schmidt, HH; Sill, H; Jager, G; Neumeister, P; Strunk, D; Linkesch, W Capillary leak syndrome with late onset after autografting for multiple myeloma.
BONE MARROW TRANSPLANT 1998 21: S91-S91.
Web of Science

1997

Full paper/article (Journal)

** Fridrik, MA; Jäger, G; Baldinger, C; Krieger, O; Chott, A; Bettelheim, P First-line treatment of Waldenström's disease with cladribine. Arbeitsgemeinschaft Medikamentöse Tumortherapie.
Ann Hematol. 1997; 74(1):7-10 Doi: 10.1007%2Fs002770050247
Web of Science PubMed FullText FullText_MUG

1996

Full paper/article (Journal)

** Osterborg, A; Boogaerts, MA; Cimino, R; Essers, U; Holowiecki, J; Juliusson, G; Jäger, G; Najman, A; Peest, D Recombinant human erythropoietin in transfusion-dependent anemic patients with multiple myeloma and non-Hodgkin's lymphoma--a randomized multicenter study. The European Study Group of Erythropoietin (Epoetin Beta) Treatment in Multiple Myeloma and Non-Hodgkin's Lymphoma.
Blood. 1996; 87(7):2675-2682 Doi: 10.1182/blood.V87.7.2675.bloodjournal8772675 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

1995

Full paper/article (Journal)

** Cazzola, M; Messinger, D; Battistel, V; Bron, D; Cimino, R; Enller-Ziegler, L; Essers, U; Greil, R; Grossi, A; Jäger, G; LeMevel, A; Najman, A; Silingardi, V; Spriano, M; van Hoof, A; Ehmer, B Recombinant human erythropoietin in the anemia associated with multiple myeloma or non-Hodgkin's lymphoma: dose finding and identification of predictors of response.
BLOOD. 1995; 86(12): 4446-4453. Doi: 10.1182/blood.V86.12.4446.bloodjournal86124446 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

1994

Full paper/article (Journal)

** Lahousen, M; Jäger, G; Girardi, F; Pickel, H; Schneeweiss, WD Incomplete Conization for Carcinoma in Site of the Uterine Cervix
ONKOLOGIE 1994 17: 150-153. Doi: 10.1159/000218400
Web of Science FullText FullText_MUG

↑ Top of page / Navigation